Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
Kawachi
Yasuhiro
Y
Koike
Yumiko
Y
Kano
Toshiyuki
T
Furuta
Junichi
J
Fujisawa
Yasuhiro
Y
Nakamura
Yasuhiro
Y
Ishii
Yoshiyuki
Y
Takahashi
Takenori
T
Otsuka
Fujio
F
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D003882:Dermatomyositis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D003937:Diagnosis, Differential; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D013274:Stomach Neoplasms / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil